A high-dose of vinflunine provides positive results and survival rates in patients with mesothelioma, based on a report in the October 20th issue of the Journal of Clinical Oncology. There have been many medications that have been evaluated for pleural mesothelioma but the response rates are usually low and no survival signs were demonstrated.

Officials said that vinflunine was generally well tolerated, but careful execution is required to minimize injecton site reactions, which resulted in about half of the patients in the study.

Source: Vinflunine improves response and survival rate in mesothelioma

Share This